Local entrepreneur Mitizi Dulan is racking up the wins, from landing on the Inc. 5000 to securing a big Target deal.
The FDA has restricted the number of patients who can receive the Cambridge drugmaker's gene therapy for Duchenne muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback